InVivo Therapeutics Holdings Profit Margin 2006-2018 | NVIV
Current and historical gross margin, operating margin and net profit margin for InVivo Therapeutics Holdings (NVIV) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. InVivo Therapeutics Holdings net profit margin as of September 30, 2018 is 0%.
|InVivo Therapeutics Holdings Annual Profit Margins
|InVivo Therapeutics Holdings Quarterly Profit Margins
||Medical Products Manufacturing
InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts.